Associated Papers
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor.
Jablonowski C et al.
Biorxiv : the Preprint Server for Biology, 2023
Arginine reprograms metabolism in liver cancer via RBM39.
Mossmann D et al.
Cell, 2023
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.
Singh S et al.
Science Advances, 2021
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
Faust TB et al.
Nature Chemical Biology, 2020
Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.
Ting TC et al.
Cell Reports, 2019
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
Wang E et al.
Cancer Cell, 2019
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Han T et al.
Science (new York, N.y.), 2017
Select a paper to view details